Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014
From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control Source: Annual Congress 2013 –The best of TB PANNET Year: 2013
Implications of the exposome and its applicability in clinical and epidemiological studies Source: International Congress 2016 – Genetics, epigenetics and the exposome Year: 2016
Clinical trials during the COVID-19 pandemic: research design and lessons Source: Eur Respir Monogr 2021; 94: 214-231 Year: 2021
Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007
What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008
The impact of a new recruitment strategy to improve recruitment of participants to research studies Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019
A new model for clinical trials to address the COVID-19 emergency Source: Breathe, 16 (2) 200220; 10.1183/20734735.0220-2020 Year: 2020
Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021
The effectiveness of telemedicine methods in the follow-up of asthma in the Covid-19 pandemic process Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
COVID-19 vaccines: immunology, regulation and clinical management Source: Eur Respir Monogr 2021; 94: 244-260 Year: 2021
Revising our approach to conducting therapeutic clinical research in COPD Source: Eur Respir J, 51 (2) 1702712; 10.1183/13993003.02712-2017 Year: 2018
Emerging challenges to the development and implementation of clinical practice guidelines – COPD as a case in point Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008
Common pitfalls in planning and conducting epidemiological and clinical research Source: Annual Congress 2008 - PG10 - Getting it right – planning, realising, analysing and publishing research projects Year: 2008
Assessing the feasibility of GSK’s clinical genetic data re-use for drug target identification and validation: A respiratory case study Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
Usefulness of the asthma predictive index in clinical practice: A systematic review and clinical epidemiological analysis Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy Year: 2012